Deciding on the therapy of multiple myeloma using genetic risk stratification.


In this issue of Leukemia and Lymphoma, Karlin and colleagues describe 102 consecutive patients who carry the t(4;14) translocation in multiple myeloma. Despite high response rates, both progression-free survival after induction therapy and progression-free survival after salvage therapy and overall survival fall far short of expectations, compared with… (More)
DOI: 10.3109/10428194.2010.542601


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.